LAM: lymphangioleiomyomatosis

Source: Breathe 2014; 10:331-332

Journal Issue: December

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
LAM: lymphangioleiomyomatosis. Breathe 2014; 10:331-332

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Lymphangioleiomyomatosis (LAM) Source: Breathe 2017; 13: 64 Year: 2017
Doxycicline in the treatment of lymphangioleiomyomatosis Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010
Experience with lung transplantation in lymphangioleiomyomatosis (LAM) in our center Source: Annual Congress 2008 - Donor organs and complications after lung transplantation Year: 2008
Histogenesis of pulmonary lymphangioleiomyomatosis Source: Eur Respir J 2003; 22: Suppl. 45, 74s Year: 2003
Differences in pulmonary function tests (PFTs) in patients with pulmonary lymphangioleiomyomatosis (LAM) and multiple benign pulmonary leiomyomatosis (MPL) Source: Eur Respir J 2004; 24: Suppl. 48, 222s Year: 2004
Lymphangioleiomyomatosis: what do we know and what are we looking for? Source: Eur Respir Rev 2011; 20: 34-44 Year: 2011
Ten-years follow-up of slowly progressive pulmonary lymphangioleiomyomatosis (PLAM) Source: Eur Respir J 2001; 18: Suppl. 33, 219s Year: 2001
Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients}, Source: Eur Respir J 2012; 40: 630-640 Year: 2012
Pulmonary function in patients with sporadic lymphangioleiomyomatosis. Source: Virtual Congress 2021 – Future advances in respiratory physiology Year: 2021
Is pulmonary rehabilitation (PR) an effective therapy in lymphangioleiomyomatosis (LAM)? Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012
Serial CT density in lymphangioleiomyomatosis (LAM) Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010
Difficulties of diagnosis of pulmonary embolism (PE) in patients with lymphangioleiomyomatosis (LAM) Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013
The changing face of a rare disease: lymphangioleiomyomatosis Source: Eur Respir J 2015; 46: 1471-1485 Year: 2015
Clinical features of lymphangioleiomyomatosis complicated by renal angiomyolipomas Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009
Pneumothorax after air travel in pulmonary lymphangioleiomyomatosis (LAM): a European survey of 145 patients Source: Eur Respir J 2005; 26: Suppl. 49, 203s Year: 2005
Lymphangioleiomyomatosis (LAM) initially presented as retroperitoneal tumour. Two case reports Source: Eur Respir J 2005; 26: Suppl. 49, 83s Year: 2005
Lymphangioleiomyomatosis Source: Eur Respir J 2006; 28: 1284 Year: 2006
Lymphangioleiomyomatosis Source: Eur Respir Mon; 2009: 46: 176–207 Year: 2009
Lymphangioleiomyomatosis Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases Year: 2008